Abstract
The aim of this study is to evaluate the biocompatibility of a new intracanal medication with silver nanoparticles (SNs), developed by researchers from the University of Ribeirão Preto (UNAERP) on fibroblast cell cultures. For this purpose, fibroblast cells from 3T3 cell line will be plated at 20,000 cells per well in 24-well plates and allowed to adhere for 24 h. The cultures will be the…